Work

A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.3095.3095

Authors: Angela Dispenzieri, Morie Abraham Gertz, Martha Q Lacy, Kristina Laumann, Betsy R. LaPlant, Shaji Kumar, Francis K Buadi, Suzanne R. Hayman, David Dingli, William J Hogan, Stephen M Ansell, Dennis A. Gastineau, David James Inwards, Ivana N. Micallef, Luis F. Porrata, Patrick B. Johnston, Mark R. Litzow, Thomas E. Witzig

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2548773794

FWCI: 0.189

Cites:

Cited by: 2

Related to: 10